InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
2
T+90 hit rate
100%
T+90 mean return
+8.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Froimson Mark, Director. Officer active across 1 company, notably Pacira BioSciences, Inc.. Cumulatively, 9 filings have been recorded. Split: 1 buy · 2 sells. Total volume traded: €80k. History available since 9 June 2021. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Froimson Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
500 shares@ US$21.8111.8% of flowCommon StockSEC:0001628280-26-019890:0
6,163 shares0Common StockSEC:0001396814-25-000085:0
1,400 shares@ US$11.5820.9% of flowCommon StockSEC:0001396814-24-000107:0
Canonical exit: 10 Nov 2024 (T+90)
5,230 shares0Common StockSEC:0001396814-24-000077:0
1,775 shares0Common StockSEC:0001209191-23-038020:0
1,160 shares0Common StockSEC:0001209191-22-035218:0
1,000 shares@ US$59.370.0053% mcap100.0% of flowCommon StockSEC:0001209191-22-028275:0
400 shares0Common StockSEC:0001209191-21-070553:0
1,066 shares0Common StockSEC:0001209191-21-040082:0
9 of 9 declarations
About Froimson Mark
Froimson Mark is Administrateur at Pacira BioSciences, Inc. (XNAS). He has 9 filings in total, and across the 9 recent filings available, buys amount to EUR 14824 and sells to EUR 65674, with filings dated from 2021-06-11 to 2026-03-19.
